An imperfect world: Assessing safety of biological treatments in SLE- In Reply.

Arthritis & rheumatology (Hoboken, N.J.)(2023)

引用 0|浏览9
暂无评分
摘要
Arthritis & RheumatologyAccepted Articles Reply An imperfect world: Assessing safety of biological treatments in SLE– In Reply April M. Jorge MD, April M. Jorge MD [email protected] orcid.org/0000-0001-6935-880X Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital Harvard Medical SchoolSearch for more papers by this authorEmma Materne MD, Emma Materne MD Department of Medicine, Massachusetts GeneralSearch for more papers by this authorBaijun Zhou MHS, Baijun Zhou MHS Division of Rheumatology, Allergy, and Immunology, Massachusetts General HospitalSearch for more papers by this authorKaren Costenbader MD, MPH, Karen Costenbader MD, MPH orcid.org/0000-0002-8972-9388 Harvard Medical School Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's HospitalSearch for more papers by this authorYuqing Zhang ScD, Yuqing Zhang ScD orcid.org/0000-0001-7638-0888 Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital Harvard Medical SchoolSearch for more papers by this authorHyon K. Choi MD, Hyon K. Choi MD orcid.org/0000-0002-2862-0442 Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital Harvard Medical SchoolSearch for more papers by this author April M. Jorge MD, April M. Jorge MD [email protected] orcid.org/0000-0001-6935-880X Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital Harvard Medical SchoolSearch for more papers by this authorEmma Materne MD, Emma Materne MD Department of Medicine, Massachusetts GeneralSearch for more papers by this authorBaijun Zhou MHS, Baijun Zhou MHS Division of Rheumatology, Allergy, and Immunology, Massachusetts General HospitalSearch for more papers by this authorKaren Costenbader MD, MPH, Karen Costenbader MD, MPH orcid.org/0000-0002-8972-9388 Harvard Medical School Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's HospitalSearch for more papers by this authorYuqing Zhang ScD, Yuqing Zhang ScD orcid.org/0000-0001-7638-0888 Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital Harvard Medical SchoolSearch for more papers by this authorHyon K. Choi MD, Hyon K. Choi MD orcid.org/0000-0002-2862-0442 Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital Harvard Medical SchoolSearch for more papers by this author First published: 31 August 2023 https://doi.org/10.1002/art.42692 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/art.42692. AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Accepted ArticlesAccepted, unedited articles published online and citable. The final edited and typeset version of record will appear in the future. RelatedInformation
更多
查看译文
关键词
biological treatments,sle–,safety
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要